Picture of Quantum Genomics SA logo

ALQGC — Quantum Genomics SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Quantum Genomics Enrolls First Patient In REFRESH Study

July 8 (Reuters) - QUANTUM GENOMICS SA  ALQGC.PA :
    * RECRUITMENT OF FIRST PATIENT IN REFRESH STUDY, PHASE 3
PIVOTAL
STUDY IN HARD-TO-TREAT WITH FIRIBASTAT HYPERTENTION
    * STUDY WILL RECRUIT 750 PATIENTS WITH RESULTS EXPECTED
MID-2023

Source text: https://bit.ly/3xpL7vB
Further company coverage:  ALQGC.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Quantum Genomics SA

See all news